Andrea
banner
andrealimbourg.bsky.social
Andrea
@andrealimbourg.bsky.social
91 followers 73 following 19 posts
Canadian 🇨🇦 in France 🇫🇷 Living with #Diabetes and #CeliacDisease #HealthPromotion #PatientPartner #PatientEducation #NothingAboutUsWithoutUs #WeAreNotWaiting
Posts Media Videos Starter Packs
Loving my new pen. Thanks @practicaldiabetic.bsky.social !! 💙 💉🖊️
Reposted by Andrea
A brief history of (commercial) AID/Looping #ATTD2025 #dedoc°
I like it too, the visual makes it so easy to understand.
@nerdabetic talking about the importance of all stakeholders engaging online about diabetes care, research and lived experience.
#ATTD2025
#dedoc°
Using both GLP-1 and CGM for people with T2D increase time in range and reduce cost and increased weight loss and increased quality of life. Helps partially by helping people to modify behaviour.
TBatellino
#ATTD2025 #dedoc°
Reposted by Andrea
As HCPs head to #ATTD2025 please remember people with Diabeties are more than just numbers we need to speak about the whole person.

Read my New Blog I Am More Than Just My Data Remembering the Person First.

pancreasimposter.blogspot.com/2025/03/i-am...

@GBDocInfo @diabetes_chat
I Am More Than Just My Data Remembering the Person First.
As someone living with diabetes, I understand that the data you see as a healthcare professional (HCP) is important. My insulin pump downloa...
pancreasimposter.blogspot.com
Podcast on diabetes and sex and relationships at the @insulet booth at #ATTD #dedoc°
Could we use the word « remission » if a perso with T2D uses CGM and has >90% of glucose levels in #TING time in normo-glycemia?
TBattellino
#ATTD2025
#dedoc°
Tbattelino cannot understand why we don’t use CGM in diagnosing T2D when you consider how the metrics changed compared to a fasting glucose value.
#ATTD2025 #dedoc°
New language at #ATTD2025:
TITR (time in tight range) or 70-140 mg/dl
becomes
TING (time in normo-glycemia).
#dedoc°
Glucise influence on brain function: Cognitive impairment starts in pre-diabetes. A case for using CGM in T2D and pre-diabetes
Tadej Battelino
#dedoc° #ATTD2025
If you have stage 2 T1D and more than 18% of time > 140 mg/dl, you are likely to progress to stage 3 T1D.

#dedoc° #ATTD2025
With auto-antibodies, we know who will progress but the « when » question is more complicated. Younger people tend to progress more quickly than older people.

#dedoc° #ATTD2025
Chantal Mathieu on early stage T1D: if you have 2 or more auto-antibodies, « the horse has left the barn », and you will develop clinical Type 1 diabetes.
#dedoc° #ATTD2025
The 4 « L »s of diabetes experience, presented by Linxi Mytkolli. All of these stakeholders need to be part of discussions regarding all facets of diabetes.
#dedoc° #attd2025
A reminder from @renzas.bsky.social to sign the #enddiabetesstigma pledge and announcing an upcoming global summit.
#attd2025 #dedoc°
Starting off #attd2025 strongly with the #dedoc° symposium. « What we wish you knew and why »
Thrilled to be a #dedoc°voice at #ATTD2025 in Amsterdam next week! Watch this space for news from the diabetes and technology world. **The #dedoc° scholarship program has paid my travel, accommodation, and access to the conference. All words are my own.
A friend was asking random diabetes questions and one was “how much insulin have I taken in my life?”

It turns out that in 10160 days of diabetes I’ve taken roughly 305000 units, which translates into a little over 3 litres. Doesn’t seem like a lot in almost 28 years!
Twitter account deleted as of yesterday. Feels weird after 15 years but I just couldn't any longer. Hello Bluesky ! 👋